Article - 24/10/2011 Cadherins and Wnt signals – cell adhesion or growth and dispersion? The proteins of the cadherin family form a kind of molecular zip that binds cells closely together thereby preventing cancer cells from migrating for example. Prof. Dr. Doris Wedlich and her team from the Karlsruhe Institute of Technology KIT were involved in the discovery that cadherins are not only involved in cell adhesion but also have other functions.https://www.gesundheitsindustrie-bw.de/en/article/news/cadherins-and-wnt-signals-cell-adhesion-or-growth-and-dispersion
Press release - 18/10/2011 New additives for high-performance bioplastics In view of dwindling reserves of fossil resources, industry is showing growing interest in bioplastics. However, compared to conventional high-performance plastics, these have their limitations – among other things in terms of stability and strength. In cooperation with Tecnaro, Henkel has now succeeded in developing new high-performance polyamide additives based on renewable raw materials that can significantly improve the performance of…https://www.biooekonomie-bw.de/en/articles/pm/new-additives-for-high-performance-bioplastics
Article - 17/10/2011 Papillomaviruses as cancer-causing agents and how they can be fought off Studies presented at the recent International Papillomavirus Conference in Berlin demonstrate that vaccination can prevent infection with the types of HPV that cause the majority of cervical cancers. New improved vaccines to prevent HPV infections as well as therapeutic vaccines that are effective in people that are already infected are currently being developed. In addition, research has shown that other cancers can also be caused by infective…https://www.gesundheitsindustrie-bw.de/en/article/news/papillomaviruses-as-cancer-causing-agents-and-how-they-can-be-fought-off
Article - 17/10/2011 A European Health Axis The research clusters of Heidelberg (Germany), Leuven (Belgium) and Cambridge (England) have launched the “Health Axis Europe” initiative, which is aimed at cross-leveraging their innovation resources and working together to increase their international competitiveness by facilitating and coordinating EU-funded collaborative R&D projects, cross-border VC investment and syndication and the cross-border exchange of scientists.https://www.gesundheitsindustrie-bw.de/en/article/news/a-european-health-axis
Article - 17/10/2011 “The only way of keeping competition in the international market at bay” Biotech companies operate mostly on a global level. This is either because they follow their customers or because their major markets are abroad or because their domestic markets are so small that they are obliged to market their products abroad. Patents do not play a key role in all industries, but are of decisive strategic importance in the biotechnology sector. "However, patents are not always the best," says Ulrike Cremer, a patent…https://www.gesundheitsindustrie-bw.de/en/article/news/the-only-way-of-keeping-competition-in-the-international-market-at-bay
Article - 17/10/2011 Aristides Arrenberg uses light to investigate the working memory Dr. Aristides Arrenberg from the University of Freiburg did his doctorate in the USA where he further developed a method that can be used to silence or activate specific zebrafish nerve cells at will. The method is based on light stimuli that trigger cellular switches. In addition the researchers have recently published an article on research into how eye movements are stored in the hindbrain. Standard network models used for so-called integrator…https://www.gesundheitsindustrie-bw.de/en/article/news/aristides-arrenberg-uses-light-to-investigate-the-working-memory
Article - 14/10/2011 Vetter - a world market leader: “We put ourselves in our clients’ shoes" We talked with Peter Soelkner Managing Director of Vetter Pharma International GmbH. Soelkner has been with Vetter since 2008. Prior to his current position Soelkner was the head of Key Account Management at Vetter before going on to work for Sartorius Stedim Biotech USA. The sales specialist has a chemical engineering degree and an MBA from Columbia University NY.https://www.gesundheitsindustrie-bw.de/en/article/news/vetter-a-world-market-leader-we-put-ourselves-in-our-clients-shoes
Press release - 12/10/2011 Autoimmune Diseases Affect Cancer Risk In a recently published study, scientists of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have calculated the interrelations between autoimmune diseases and cancer of the digestive tract. They discovered that many autoimmune diseases increase the cancer risk, while others, such as rheumatism, are associated with a significantly lower bowel cancer risk. These differing impacts on cancer risk may be attributable to the…https://www.gesundheitsindustrie-bw.de/en/article/press-release/autoimmune-diseases-affect-cancer-risk
Press release - 12/10/2011 Don't give micro-organisms a chance - Development of antimicrobial workwear As part of a research project (IGF No. 16039 BG), scientists at the Hohenstein Institute, in cooperation with the Thüringen Institute for Textile and Plastics Research and the Saxony Textile Research Institute at the Technical University of Chemnitz, have developed a fabric for making antimicrobial workwear suitable for leasing that is based on regenerated cellulose fibres, and they have examined it with regard to its properties when it is used…https://www.biooekonomie-bw.de/en/articles/pm/don-t-give-micro-organisms-a-chance-development-of-antimicrobial-workwear
Press release - 12/10/2011 Dioxin-like Chemical Messenger Makes Brain Tumors More Aggressive Scientists from German Cancer Research Center and Heidelberg University have discovered a new dioxin receptor-coupled metabolic pathway which weakens the immune system and promotes the growth of malignant gliomas. Glioma is the most frequent and most malignant brain tumor in adults. In Germany, about 4,500 people are newly diagnosed with glioma every year.https://www.gesundheitsindustrie-bw.de/en/article/press-release/dioxin-like-chemical-messenger-makes-brain-tumors-more-aggressive
Article - 10/10/2011 Meet & Match in the BioValley – bringing together international partners Small life sciences companies find it particularly difficult to set aside time for making international contacts at trade fairs. The BioValley cluster located in a region bordered by Germany France and Switzerland has a team of scouts that focus on matchmaking. Dr. Mona Boy is the coordinator of the trinational matchmaking team of the BioValley cluster.https://www.gesundheitsindustrie-bw.de/en/article/news/meet-match-in-the-biovalley-bringing-together-international-partners
Press release - 10/10/2011 Vetter’s state-of-the-art Chicago facility is fully operational Vetter, a leading contract development and manufacturing organization that specializes in aseptic filling, today announced that its first U.S. facility is now fully operational. Located at the Illinois Science + Technology Park in suburban Chicago, the 24,000-square-foot site includes microbiology and chemical analysis labs, material preparation and compounding functions, three cleanrooms for aseptic filling, and visual inspection. The first to…https://www.gesundheitsindustrie-bw.de/en/article/press-release/vetter-s-state-of-the-art-chicago-facility-is-fully-operational
Article - 10/10/2011 Ambassador for Germany’s science landscape The name Alexander von Humboldt is synonymous with the best ambassador for Germany as a country of science. The Alexander von Humboldt Foundation launched the ideas competition “Research alumni of universities in Germany” in April 2011 and the winners have now been selected. The University of Heidelberg is one of the three winners and was awarded a prize for its best practice model for working with the university’s research alumni.https://www.gesundheitsindustrie-bw.de/en/article/news/ambassador-for-germany-s-science-landscape
Dossier - 10/10/2011 Global players in theory but not always in practice Biotechnology companies have always had international ties: they employ cutting-edge technologies and market the discoveries and developments of researchers around the world. Rapid innovation cycles and rapid technological developments force companies to undertake costly R&D as well as market their products and/or services across national borders.https://www.gesundheitsindustrie-bw.de/en/article/dossier/global-players-in-theory-but-not-always-in-practice
Dossier - 10/10/2011 Global players in theory but not always in practice Biotechnology companies have always had international ties: they employ cutting-edge technologies and market the discoveries and developments of researchers around the world. Rapid innovation cycles and rapid technological developments force companies to undertake costly R&D as well as market their products and/or services across national borders.https://www.biooekonomie-bw.de/en/articles/dossiers/global-players-in-theory-but-not-always-in-practice
Article - 10/10/2011 Internationalization is firmly anchored in the company DNA The establishment of a subsidiary in London in 2004 heralded the presence on the international market of Konstanz-based GATC, which now has subsidiaries in England, France and Sweden comprising a total of 22 sales offices and laboratories. Twenty-five of the company’s 150 or so employees work in production and sales outside Germany. Peter Pohl, CEO of Europe’s leading provider of DNA services, explains in the following interview what he considers…https://www.gesundheitsindustrie-bw.de/en/article/news/internationalization-is-firmly-anchored-in-the-company-dna
Dossier - 05/10/2011 Biosimilars: follow-on biologics of innovator biopharmaceutical products As blockbuster biopharmaceuticals go off patent, biosimilars are increasingly competing with them for a market share. However, the production of biosimilars is rather complex and costly. The approval of biosimilars is also subject to many hurdles. Their introduction to the very expensive biopharmaceuticals market is often associated with marginal price reductions.https://www.gesundheitsindustrie-bw.de/en/article/dossier/biosimilars-follow-on-biologics-of-innovator-biopharmaceutical-products
Press release - 04/10/2011 European joint conference on chemical engineering and biotechnology in Berlin end on an upbeat note The 8th European Congress of Chemical Engineering and 1st European Congress of Applied Biotechnology closed on Thursday in Berlin on an upbeat note. For four days, about 3,000 scientists from industry and academia discussed topics from research and practical application. Especially the lectures on downstream processing of biotechnological products were strongly frequented; sessions on energy storage, future thinking in innovation and process…https://www.gesundheitsindustrie-bw.de/en/article/press-release/european-joint-conference-on-chemical-engineering-and-biotechnology-in-berlin-end-on-an-upbeat-note
Article - 04/10/2011 Matias Simons: planar cell polarity and wound healing with electrical signals The planar cell polarity is crucial for example in the development of ordered organ structures. One of the issues being investigated by researchers led by Prof. Dr. Matias Simons from the University of Freiburg is how the perfectly ordered patterns on the surface of Drosophila wings develop.https://www.gesundheitsindustrie-bw.de/en/article/news/matias-simons-planar-cell-polarity-and-wound-healing-with-electrical-signals
Press release - 04/10/2011 European joint conference on chemical engineering and biotechnology in Berlin end on an upbeat note The 8th European Congress of Chemical Engineering and 1st European Congress of Applied Biotechnology closed on Thursday in Berlin on an upbeat note. For four days, about 3,000 scientists from industry and academia discussed topics from research and practical application. Especially the lectures on downstream processing of biotechnological products were strongly frequented; sessions on energy storage, future thinking in innovation and process…https://www.biooekonomie-bw.de/en/articles/pm/european-joint-conference-on-chemical-engineering-and-biotechnology-in-berlin-end-on-an-upbeat-note
Article - 04/10/2011 Cell biologist to be awarded first “Distinguished Guest Professorship“ in Tübingen Every year for the next three years, the Russian molecular biologist and medical doctor Prof. Dr. Peter M. Chumakov is to spend one to two weeks researching and lecturing at the University of Tübingen. This special form of international exchange is being funded for three years by the Baden-Württemberg government with the aim of strengthening Tübingen’s competence through cooperation with distinguished scientists from other universities.https://www.gesundheitsindustrie-bw.de/en/article/news/cell-biologist-to-be-awarded-first-distinguished-guest-professorship-in-tuebingen
Press release - 03/10/2011 BioIndustry 2021: Meet German leading-edge clusters at BIOTECHNICA 2011 Four of the five clusters that have won the BMBF “BioIndustry 2021” competition will be present at a joint booth at BIOTECHNICA, Europe’s leading trade fair for biotechnology and the life sciences to be held in Hanover, Germany from 11th to 13th October. They will be presenting insights into visions they have been working on and talking about their place in the industrial biotechnology sector of the future.https://www.biooekonomie-bw.de/en/articles/pm/bioindustry-2021-meet-german-leading-edge-clusters-at-biotechnica-2011
Press release - 03/10/2011 Astonishing discovery: iron-overloading of macrophages is the cause of venous leg ulcers Around three to five per cent of people in industrial nations suffer from chronic venous leg ulcers. Elderly people are particularly prone to developing these chronic wounds. A dermatologist from Ulm has now discovered the reason why chronic venous leg ulcers fail to heal even after months or years. The scientific community is astonished by the new findings.https://www.gesundheitsindustrie-bw.de/en/article/press-release/astonishing-discovery-iron-overloading-of-macrophages-is-the-cause-of-venous-leg-ulcers
Press release - 30/09/2011 Blood Vessels from Your Printer Researchers have been working at growing tissue and organs in the laboratory for a long time. These days, tissue engineering enables us to build up artificial tissue, although science still hasn’t been successful with larger organs. Now, researchers at Fraunhofer are applying new techniques and materials to come up with artificial blood vessels in their BioRap project that will be able to supply artificial tissue and maybe even complex organs in…https://www.gesundheitsindustrie-bw.de/en/article/press-release/blood-vessels-from-your-printer
Press release - 29/09/2011 Baden-Württemberg biotechnology industry report released The 32-page biotechnology industry report entitled Wirtschaftsfaktor Biotechnologie Daten und Fakten für Baden-Württemberg Economic Impact of Biotechnology Facts and Figures for Baden-Württemberg is the first ever report to shed light on why Baden-Württemberg is one of the most important life sciences locations in Europe. The report presents industry data highlights key location factors and looks into issues such as company foundation financing…https://www.bio-pro.de/en/information/press-release/baden-wuerttemberg-biotechnology-industry-report-released